ES452060A1 - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
ES452060A1
ES452060A1 ES452060A ES452060A ES452060A1 ES 452060 A1 ES452060 A1 ES 452060A1 ES 452060 A ES452060 A ES 452060A ES 452060 A ES452060 A ES 452060A ES 452060 A1 ES452060 A1 ES 452060A1
Authority
ES
Spain
Prior art keywords
ring
lower alkyl
bromine
sulfur
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES452060A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES452060A1 publication Critical patent/ES452060A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedure to prepare antihistamine compounds, of general formula: **(See formula)** wherein Het'is a 2- or 4-imidazolyl ring optionally substituted by lower alkyl (preferably methyl, halogen (preferably chlorine or bromine), trifluoromethyl or hydroxymethyl, a 2-pyridyl ring optionally substituted by lower alkyl (preferably methyl), lower alkoxy (preferably methoxy, halogen (preferably chlorine or bromine), amino or hydroxy, a 2-thiazolyl ring, a 3-isothiazolyl ring optionally substituted by chlorine or bromine, a 3- (l, 2,5) -thiadiazolyl ring optionally substituted by chlorine or bromine, or a 2- (5-amino-1,3,4-thiazolyl) ring; z is sulfur or a methylene group; X is oxygen or sulfur; W is methylene, oxygen or sulfur; m and n are such that their sum is 1 to 4 when w is oxygen or sulfur, or 0 to 4 when W is methylene; A is a 1- or 2-naphthyl ring, a 2,3-dihydro-1,4-benzodioxynyl ring or a 1,3-benzodioxolyl ring, a phenyl ring substituted with 1 or more lower alkyl, lower alkoxy, halogen, arylalkoxy, hydro groups xi, alkoxyalkoxy, trifluoromethyl, di (lower alkyl) amino, phenoxy, halophenoxy, alkoxyphenoxy, phenyl, halophenyl or alkoxyphenyl and when - (CH2) mW (CH2) - is not a methylene group. A can also be phenyl; e is hydrogen or lower alkyl; characterized in that it comprises reacting an amine of the formula: **(See formula)** where Het'and z are defined as above, with a compound of the formula: **(See formula)** where X, Y3, m, W, n and A are defined as above and Q is lower alkylthio, benzylthio, halogen or other reactive group conveniently displaced by an amine. (Machine-translation by Google Translate, not legally binding)
ES452060A 1975-10-02 1976-10-01 Heterocyclic compound Expired ES452060A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02

Publications (1)

Publication Number Publication Date
ES452060A1 true ES452060A1 (en) 1977-10-01

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
ES452060A Expired ES452060A1 (en) 1975-10-02 1976-10-01 Heterocyclic compound

Country Status (36)

Country Link
JP (2) JPS5246087A (en)
AR (1) AR221682A1 (en)
AT (1) AT358045B (en)
AU (1) AU504897B2 (en)
BE (1) BE846452A (en)
BG (1) BG25224A3 (en)
CA (1) CA1067076A (en)
CH (1) CH625801A5 (en)
CS (1) CS203003B2 (en)
DD (1) DD126563A5 (en)
DE (1) DE2643670C2 (en)
DK (1) DK442476A (en)
ES (1) ES452060A1 (en)
FI (1) FI61701C (en)
FR (1) FR2326192A1 (en)
GR (1) GR61307B (en)
HU (1) HU175537B (en)
IE (1) IE44845B1 (en)
IL (1) IL50503A (en)
IN (1) IN146736B (en)
IT (2) IT1070839B (en)
LU (1) LU75922A1 (en)
MW (1) MW3476A1 (en)
MX (1) MX4614E (en)
NL (1) NL7609917A (en)
NO (1) NO145792C (en)
NZ (1) NZ181959A (en)
OA (1) OA05445A (en)
PH (1) PH13921A (en)
PL (1) PL105828B1 (en)
PT (1) PT65590B (en)
RO (1) RO73511A (en)
SE (1) SE431872B (en)
YU (1) YU237276A (en)
ZA (1) ZA765498B (en)
ZM (1) ZM12176A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (en) * 1978-02-13 1983-03-05 Smith Kline French Lab
IL57005A (en) * 1978-04-11 1983-11-30 Smith Kline French Lab Process for the preparation of 2-amino pyrimid-4-one derivatives and novel 2-nitroaminopyrimid-4-ones as intermediates therefor
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
JPS5993074A (en) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド Pyrimidone derivative
DE8309239U1 (en) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen TAPE REEL, IN PARTICULAR FOR MAGNETIC TAPES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
NZ181959A (en) 1978-07-28
DE2643670C2 (en) 1982-07-01
IE44845B1 (en) 1982-04-21
PL105828B1 (en) 1979-11-30
MX4614E (en) 1982-07-07
IL50503A (en) 1980-12-31
DE2643670A1 (en) 1977-04-14
NO763371L (en) 1977-04-05
IT7830708A0 (en) 1978-12-11
ATA711976A (en) 1980-01-15
HU175537B (en) 1980-08-28
RO73511A (en) 1981-04-30
CA1067076A (en) 1979-11-27
JPS5246087A (en) 1977-04-12
PT65590A (en) 1976-10-01
SE431872B (en) 1984-03-05
NL7609917A (en) 1977-04-05
LU75922A1 (en) 1977-05-06
JPS5695186A (en) 1981-08-01
FR2326192A1 (en) 1977-04-29
NO145792C (en) 1982-06-02
CS203003B2 (en) 1981-02-27
IT1070839B (en) 1985-04-02
JPS5635674B2 (en) 1981-08-19
YU237276A (en) 1983-01-21
AR221682A1 (en) 1981-03-13
AU1829576A (en) 1978-04-06
MW3476A1 (en) 1977-11-09
FI762803A (en) 1977-04-03
DK442476A (en) 1977-04-03
FR2326192B1 (en) 1979-01-12
FI61701C (en) 1982-09-10
BE846452A (en) 1977-03-22
GR61307B (en) 1978-10-19
JPS609755B2 (en) 1985-03-12
PT65590B (en) 1978-03-28
ZM12176A1 (en) 1977-07-21
PH13921A (en) 1980-11-04
FI61701B (en) 1982-05-31
DD126563A5 (en) 1977-07-27
IN146736B (en) 1979-08-25
OA05445A (en) 1981-03-31
IE44845L (en) 1977-04-02
AU504897B2 (en) 1979-11-01
NO145792B (en) 1982-02-22
SE7610409L (en) 1977-04-03
AT358045B (en) 1980-08-11
CH625801A5 (en) 1981-10-15
IL50503A0 (en) 1976-11-30
BG25224A3 (en) 1978-08-10
ZA765498B (en) 1977-08-31

Similar Documents

Publication Publication Date Title
ES452060A1 (en) Heterocyclic compound
ES454656A1 (en) Heterocyclic compounds
FI802740A (en) 3,4-DISUBSTITUTES 1,2,5-THIADIAZOLE-1-OXIDER OCH 1,1-DIOXIDER
ATE246171T1 (en) AMINOSULFONYL CARBAMATES
KR870004981A (en) Process for the preparation of heterocyclic oxophthalazinyl acetic acid
FI954965A0 (en) AMPA antagonists and treatment method where used
IE802684L (en) Quinoline derivatives
FI892362A (en) BUTEN- ELLER PROPENSYRADERIVAT.
SE8006365L (en) CYKLOHEXANKARBOXYLSYRADERIVAT
ES405982A1 (en) Aza-benzimidazoles
ES450309A1 (en) Pharmacologically active compounds 4-substituted-imidazole-5-methanols
ES467953A1 (en) Pharmacologically active triazinones
ATE50574T1 (en) AMINOPYRIMIDINONES AS HISTAMINE H2 ANTAGONISTS.
ES8604603A1 (en) Ulcer and gastric secretion inhibiting 4,5,6,7-tetrahydrothiazole[5,4-c]pyridine derivatives
DE3264253D1 (en) PYRIDINE DERIVATIVES AS HISTAMINE H2 ANTAGONISTS
ATE34978T1 (en) IMIDAZOLINONE DERIVATIVES AS HISTAMINE H2 ANTAGONISTS.
AU532634B2 (en) Thiazolyl derivatives
SE8005493L (en) 4- (HAFTALENYLOXI) PIPERIDINE DERIVATIVES
DK110480A (en) METHOD OF PENICILLIN PREPARATION
SE8303131D0 (en) ISOQUINOLINE DERIVATIVES
ES479738A1 (en) Procedure for preparing pyrimidones. (Machine-translation by Google Translate, not legally binding)
TH1858A (en) Chemical process
KR840003257A (en) Method of manufacturing penam derivatives
FR2525606B1 (en)
TH4274EX (en) New heterocyclic compounds